NO143942C - Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner

Info

Publication number
NO143942C
NO143942C NO752330A NO752330A NO143942C NO 143942 C NO143942 C NO 143942C NO 752330 A NO752330 A NO 752330A NO 752330 A NO752330 A NO 752330A NO 143942 C NO143942 C NO 143942C
Authority
NO
Norway
Prior art keywords
preparation
pharmacologically active
heterocyclic substituted
substituted guanidines
analogy procedure
Prior art date
Application number
NO752330A
Other languages
English (en)
Norwegian (no)
Other versions
NO752330L (fr
NO143942B (no
Inventor
Graham John Durant
Charon Robin Ganellin
Geoffrey Robert Owen
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NO752330L publication Critical patent/NO752330L/no
Publication of NO143942B publication Critical patent/NO143942B/no
Publication of NO143942C publication Critical patent/NO143942C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO752330A 1974-06-28 1975-06-27 Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner NO143942C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28722/74A GB1497260A (en) 1974-06-28 1974-06-28 Guanidine derivatives

Publications (3)

Publication Number Publication Date
NO752330L NO752330L (fr) 1975-12-30
NO143942B NO143942B (no) 1981-02-02
NO143942C true NO143942C (no) 1981-05-13

Family

ID=10280055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752330A NO143942C (no) 1974-06-28 1975-06-27 Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner

Country Status (20)

Country Link
US (1) US4034101A (fr)
JP (1) JPS5946221B2 (fr)
AU (1) AU503858B2 (fr)
BE (1) BE830272A (fr)
CA (1) CA1076579A (fr)
CH (1) CH615669A5 (fr)
DE (1) DE2528639A1 (fr)
DK (1) DK268975A (fr)
ES (1) ES438944A1 (fr)
FR (1) FR2276042A1 (fr)
GB (1) GB1497260A (fr)
IE (1) IE41625B1 (fr)
IL (1) IL47394A (fr)
LU (1) LU72835A1 (fr)
NL (1) NL7506951A (fr)
NO (1) NO143942C (fr)
PH (1) PH14275A (fr)
PL (1) PL98616B1 (fr)
SE (1) SE417961B (fr)
ZA (1) ZA753455B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5014808U (fr) * 1973-06-06 1975-02-17
JPS55822B2 (fr) * 1973-07-09 1980-01-10
US4197305A (en) * 1974-02-07 1980-04-08 Smith Kline & French Laboratories Limited Thiazole, isothiazole, oxazole and isoxazole compounds
US4133886A (en) * 1974-02-07 1979-01-09 Smith Kline & French Laboratories Limited Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
GB1496787A (en) * 1974-03-12 1978-01-05 Smith Kline French Lab Heteroalkylthioalkyl amidine derivatives
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
JPS5912767Y2 (ja) * 1974-03-28 1984-04-17 アイワ カブシキガイシヤ 回転機器の作動切換装置
US4093729A (en) * 1974-06-28 1978-06-06 Smith Kline & French Laboratories Limited N-Oxy and N-amino guanidines
US4192879A (en) * 1975-05-21 1980-03-11 Smith Kline & French Laboratories Limited Imidazolyl alkylamino nitroethylene compounds
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
GB1564502A (en) * 1975-07-31 1980-04-10 Smith Kline French Lab Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
US4108859A (en) * 1977-06-06 1978-08-22 The Dow Chemical Company Microbicidal (pyridinylamino) alkyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0006679B1 (fr) 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Dérivés antisécréteurs de thiadiazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
CA1140925A (fr) * 1978-10-16 1983-02-08 Derrick F. Jones Derives heterocycliques anti-secretion, a chaine ramifiee, procedes pour les fabriquer et compositions pharmaceutiques qui en contiennent
JPS56124143A (en) * 1980-02-29 1981-09-29 Sanyo Electric Co Ltd Control mechanism of tape recorder
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
JPS6156012U (fr) * 1984-09-19 1986-04-15
JPS61228914A (ja) * 1985-04-04 1986-10-13 Sumitomo Heavy Ind Ltd 成形用金型
JPH0347862Y2 (fr) * 1985-12-14 1991-10-14
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines

Also Published As

Publication number Publication date
FR2276042A1 (fr) 1976-01-23
NL7506951A (nl) 1975-12-30
AU503858B2 (en) 1979-09-27
GB1497260A (en) 1978-01-05
FR2276042B1 (fr) 1980-04-25
LU72835A1 (fr) 1975-10-08
ZA753455B (en) 1976-04-28
NO752330L (fr) 1975-12-30
PL98616B1 (pl) 1978-05-31
SE417961B (sv) 1981-04-27
ES438944A1 (es) 1977-02-16
AU8230475A (en) 1976-12-23
US4034101A (en) 1977-07-05
CA1076579A (fr) 1980-04-29
JPS5119766A (fr) 1976-02-17
SE7507364L (sv) 1975-12-29
IE41625L (en) 1975-12-28
IE41625B1 (en) 1980-02-13
IL47394A (en) 1980-01-31
IL47394A0 (en) 1975-07-28
PH14275A (en) 1981-04-29
JPS5946221B2 (ja) 1984-11-10
NO143942B (no) 1981-02-02
DK268975A (da) 1975-12-29
CH615669A5 (fr) 1980-02-15
DE2528639A1 (de) 1976-01-15
BE830272A (fr) 1975-12-16

Similar Documents

Publication Publication Date Title
NO143942C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive heterocyklisk substituerte guanidiner
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO142402C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzimidazoler
NO145199C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145842C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater
NO143315C (no) Analogifremgangsmaate ved fremstilling av farmakologisk aktive bis-imidazol-derivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO142524C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO142403C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner.
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
NO141608C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater